Suppr超能文献

重组人睫状神经营养因子在肌萎缩侧索硬化症患者中的毒性和耐受性

Toxicity and tolerability of recombinant human ciliary neurotrophic factor in patients with amyotrophic lateral sclerosis.

作者信息

Miller R G, Bryan W W, Dietz M A, Munsat T L, Petajan J H, Smith S A, Goodpasture J C

机构信息

Department of Neurology, California Pacific Medical Center, San Francisco, USA.

出版信息

Neurology. 1996 Nov;47(5):1329-31. doi: 10.1212/wnl.47.5.1329.

Abstract

We examined the toxicity of both single and multiple subcutaneous injections of recombinant human ciliary neurotrophic factor (rhCNTF) in 72 patients with ALS, in doses ranging from 2 to 100 micrograms/kg. Adverse events were generally dose related and ranged from mild to severe. The tolerability of daily subcutaneous rhCNTF was equivalent to placebo at doses < or = 5 micrograms/kg/day. At higher doses, anorexia, weight loss, reactivation of herpes simplex virus (HSV1) labialis/stomatitis, cough, and increased oral secretions occurred.

摘要

我们对72例肌萎缩侧索硬化症(ALS)患者皮下注射单剂量及多剂量重组人睫状神经营养因子(rhCNTF)的毒性进行了研究,剂量范围为2至100微克/千克。不良事件一般与剂量相关,程度从轻度到重度不等。每日皮下注射rhCNTF,剂量≤5微克/千克/天时,其耐受性与安慰剂相当。在更高剂量时,出现了厌食、体重减轻、唇/口腔单纯疱疹病毒1型(HSV1)复发/口腔炎、咳嗽和口腔分泌物增多等情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验